carbostyril has been researched along with Carcinoma, Small Cell in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Estrada, L; Gonzalez, AL; Jiang, A; Massion, PP; Miller, AN; Ocak, S; Quaranta, V; Shyr, Y; Udyavar, AR; Yamashita, H; Yi, Y; Zou, Y | 1 |
Smit, EF | 1 |
Heymach, JV; Johnson, BE | 1 |
De Porre, PM; DeVore, RF; Heymach, JV; Jia, X; Johnson, BE; Johnson, DH; Khuri, FR; Richards, HM; Safran, H; Schlabach, LL; Yunus, F; Zhang, S | 1 |
Hamel, E; Kuo, SC; Lednicer, D; Lee, KH; Li, L; Lin, CM; Wang, HK; Wu, TS | 1 |
1 review(s) available for carbostyril and Carcinoma, Small Cell
Article | Year |
---|---|
Farnesyl transferase inhibitors for patients with lung cancer.
Topics: Alkyl and Aryl Transferases; Apoptosis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Farnesyltranstransferase; Humans; Imidazoles; Lung Neoplasms; Quinolones; Signal Transduction; Treatment Outcome | 2004 |
1 trial(s) available for carbostyril and Carcinoma, Small Cell
Article | Year |
---|---|
Phase II study of the farnesyl transferase inhibitor R115777 in patients with sensitive relapse small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Alkyl and Aryl Transferases; Carcinoma, Small Cell; Disease-Free Survival; Farnesyltranstransferase; Female; Humans; Lung Neoplasms; Male; Middle Aged; Quinolones; Recurrence; Signal Transduction; Treatment Outcome | 2004 |
3 other study(ies) available for carbostyril and Carcinoma, Small Cell
Article | Year |
---|---|
DNA copy number aberrations in small-cell lung cancer reveal activation of the focal adhesion pathway.
Topics: Carcinoma, Small Cell; Cell Adhesion; Cell Line, Tumor; Comparative Genomic Hybridization; Focal Adhesion Protein-Tyrosine Kinases; Focal Adhesions; Gene Dosage; Humans; Lung Neoplasms; Quinolones; Sulfones | 2010 |
[New data presented at ASCO 2002 concerning small cell bronchial cancer].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Carboplatin; Carcinoma, Small Cell; Cisplatin; Deoxycytidine; Etoposide; Gemcitabine; Humans; Imatinib Mesylate; Lung Neoplasms; Piperazines; Prognosis; Pyrimidines; Quinolones; Smoking; Smoking Prevention; Survival Analysis; Treatment Outcome | 2002 |
Antitumor agents. 150. 2',3',4',5',5,6,7-substituted 2-phenyl-4-quinolones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Small Cell; Cattle; Cell Division; Central Nervous System Neoplasms; Colonic Neoplasms; Female; Humans; Leukemia; Lung Neoplasms; Molecular Structure; Polymers; Quinolones; Structure-Activity Relationship; Tubulin; Tubulin Modulators; Tumor Cells, Cultured | 1994 |